Cargando…
Effect of antitumor therapy on cancer patients infected by SARS‐CoV‐2: A systematic review and meta‐analysis
BACKGROUND: Cancer patients are at a high risk of being infected with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), and are more likely to develop severe illness and have higher mortality once infected. In the COVID‐19 pandemic, it is urgent to understand the effects of antitumor the...
Autores principales: | Li, Piao, Li, Lingling, Wang, Shennan, Liu, Yu, Li, Zhou, Xia, Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7940220/ https://www.ncbi.nlm.nih.gov/pubmed/33547886 http://dx.doi.org/10.1002/cam4.3754 |
Ejemplares similares
-
Asymptomatic detection of SARS‐CoV‐2 among cancer patients receiving infusional anti‐cancer therapy
por: Shaya, Justin, et al.
Publicado: (2021) -
SARS-CoV-2 infections in pediatric and young adult recipients of chimeric antigen receptor T-cell therapy: an international registry report
por: McNerney, Kevin Owen, et al.
Publicado: (2023) -
SARS‐CoV‐2 infections in cancer outpatients—Most infected patients are asymptomatic carriers without impact on chemotherapy
por: Hempel, Louisa, et al.
Publicado: (2020) -
Time to SARS‐CoV‐2 clearance among patients with cancer and COVID‐19
por: Xu, Wenxin, et al.
Publicado: (2021) -
The serological prevalence of SARS‐CoV‐2 infection in patients with chronic myeloid leukemia is similar to that in the general population
por: Bonifacio, Massimiliano, et al.
Publicado: (2021)